GRIP Molecular Technologies
Likely to Engage tag.Highly Engaged Employees

Business Services · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Manufacturing Research & Development Medical Devices & Equipment
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About GRIP Molecular Technologies

GRIP Molecular Technologies specializes in next-generation diagnostics, offering a molecular test platform for lateral flow assays that detects pathogen RNA and provides accurate results in minutes without nucleic acid amplification. Their CRISPR protease engine delivers lab-grade results at room temperature, making it adaptable for various sample types including saliva, swabs, and urine. The technology is designed to meet the needs of point-of-need and point-of-care diagnostics, particularly for sexually transmitted infections, urinary tract infections, and upper respiratory infections. By providing fast, accurate, and affordable testing solutions, GRIP aims to close the gap in access to essential diagnostic tools in clinics and community health programs.Explore more
Popular SearchesGRIP Molecular Technologies IncGripSIC Code 38,382NAICS Code 33,334Show more

GRIP Molecular Technologies Org Chart

PhoneEmail
BB
United States flag for contact location.

Founder & President, CSO

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is GRIP Molecular Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to GRIP Molecular Technologies

Compare insights from companies similar to GRIP Molecular Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

GRIP Molecular Technologi...

<$5M
1-10
Private
-
2019
BB
Bruce BattenFounder & President, CSO
$6.5M
11-50
Public
$340.5M
2015
JP
Jason PtacekDirector of Translational Science and Biomarkers
<$5M
11-50
Private
-
2015
<$5M
11-50
Private
<$5M
2004
Jennifer Dent, President & Chief Executive Officer at Bio Ventures for Global Health
Jennifer DentPresident & CEO
<$5M
11-50
Private
$23.1M
2016
CM
Connie MuchaSenior Executive Administrator
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
Michal Silverberg, Managing Director at Novartis Venture Fund
Michal SilverbergManaging Director
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

GRIP Molecular Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

GRIP Molecular Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GRIP Molecular Technologies.

GRIP Molecular Technologies Tech Stack

A closer look at the technologies used by GRIP Molecular Technologies

GRIP Molecular Technologies News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding GRIP Molecular Technologies

What is GRIP Molecular Technologies's official website?
GRIP Molecular Technologies's official website is www.gripmolecular.com
What is GRIP Molecular Technologies's Revenue?
GRIP Molecular Technologies's revenue is <$5 Million
What is GRIP Molecular Technologies's SIC code?
GRIP Molecular Technologies's SIC: 38,382
What is GRIP Molecular Technologies's NAICS code?
GRIP Molecular Technologies's NAICS: 33,334
How many employees does GRIP Molecular Technologies have?
GRIP Molecular Technologies has 1-10 employees
What industry does GRIP Molecular Technologies belong to?
GRIP Molecular Technologies is in the industry of: Business Services, Manufacturing, Research & Development
What is GRIP Molecular Technologies competition?
GRIP Molecular Technologies top competitors include: Systems Oncology, Artizan Biosciences, American Association for Precision Medicine, Bio Ventures for Global Health
What technology does GRIP Molecular Technologies use?
Some of the popular technologies that GRIP Molecular Technologies uses are: Google Cloud DNS, Google Cloud Platform, Google Workspace, Gmail
What does GRIP Molecular Technologies do?

GRIP Molecular Technologies specializes in next-generation diagnostics, offering a molecular test platform for lateral flow assays that detects pathogen RNA and provides accurate results in minutes without nucleic acid amplification. Their CRISPR protease engine delivers lab-grade results at room temperature, making it adaptable for various sample... types including saliva, swabs, and urine. The technology is designed to meet the needs of point-of-need and point-of-care diagnostics, particularly for sexually transmitted infections, urinary tract infections, and upper respiratory infections. By providing fast, accurate, and affordable testing solutions, GRIP aims to close the gap in access to essential diagnostic tools in clinics and community health programs.Read More

Is GRIP Molecular Technologies a public company?
GRIP Molecular Technologies is private company therefore does not currently have an official ticker symbol
See more information about GRIP Molecular Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.